Audicus Omni 2 vs Elehear Beyond

The Audicus Omni 2 is a premium-priced behind-the-ear OTC hearing aid available for $1,898. With a SoundScore of 4.6/5 and an A grade, it ranks #5 among 65 OTC hearing aids tested, placing it in the top 6% of its category. In our lab testing, the Omni 2 demonstrates strong speech clarity in quiet environments, scoring 4.2/5—well above the category average by 1.38 points. Speech in noise performance is more modest at 2.3/5, which is above the category average by 0.79 points but mixed in absolute terms. This pattern suggests the device handles everyday conversations well while challenging listening situations may still present difficulty. Music streaming is a particular strength, scoring 3.6/5 and exceeding the category average by a substantial 1.68 points. Feedback handling is excellent at 4.5/5, virtually matching the category average. Own-voice comfort scores a solid 3.0/5, which is 0.49 points above average for OTC devices. The Omni 2 offers both rechargeable and disposable battery options, along with streaming compatibility for iPhone and Android devices with hands-free capability. It has earned Expert's Choice Awards for both 2023 and 2024. Consumers seeking alternatives in this price range may also consider the similarly-priced Lucid Tala, while the lower-priced Lexie B3 offers competitive performance for those with tighter budgets.

The Elehear Beyond is a behind-the-ear OTC hearing aid priced at $431, earning an A grade with a SoundScore of 4.3/5. This places it in the top 11% of all OTC hearing aids tested, ranking #8 out of 65 devices in its category—a standout result for a budget-tier product. In our lab testing, the Beyond demonstrates particular strength in speech clarity for quiet environments, scoring 4.3/5—a full 1.48 points above the OTC category average. Music streaming quality is another highlight at 3.8/5, measuring 1.88 points above average and delivering solid fidelity for phone audio. Speech understanding in noisy situations scores 2.3/5, which is 0.83 points above the category average but remains mixed in absolute terms—a common limitation among OTC devices. Feedback handling is excellent at 4.5/5, providing stable performance during typical use. Own-voice comfort scores 2.6/5, slightly above the category average but still in mixed territory, which may be noticeable for some users during conversation. The Beyond earned a 2024 Expert's Choice Award and represents strong value in the budget OTC segment. It outperforms several same-price competitors including the Apple AirPods Pro 2 and Zepp Clarity Omni. This device is best suited for those seeking reliable speech clarity in quieter settings and quality streaming audio without the higher cost of prescription alternatives.